Moderna stock price chart
WebModerna fends off Arbutus appeal in COVID-19 vaccine patent fight. (Reuters) -A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an … Web24 mrt. 2024 · Moderna Inc. options data by MarketWatch. View MRNA option chain data and pricing information for given maturity periods.
Moderna stock price chart
Did you know?
Web11 apr. 2024 · According to the issued ratings of 13 analysts in the last year, the consensus rating for Moderna stock is Hold based on the current 2 sell ratings, 4 hold ratings and 7 buy ratings for MRNA. The average twelve-month price prediction for Moderna is $180.80 with a high price target of $296.00 and a low price target of $93.00. Web1 dag geleden · Analyst Forecast. According to 27 analysts, the average rating for MRNA stock is "Buy." The 12-month stock price forecast is $231.18, which is an increase of …
Web6 mrt. 2024 · Moderna is an attractive growth stock if you want to invest in the biotech sector. With a performance of more than 500% in only 3 years, this stock has already … Web10 apr. 2024 · The bank's $160 price target implies the stock can rally 24% over the next 12 months. "Although the near-term path is likely to remain choppy, we believe the current valuation provides an ...
Web21 uur geleden · Motley Fool - Fri Apr 14, 4:30AM CDT. Vaccine sales have been on the decline, so you may think it's too late to buy Pfizer(NYSE: PFE) stock. After all, the big-pharma company is the vaccine leader ... WebModerna Stock Forecast, MRNA stock price prediction. Price target in 14 days: 168.104 USD. The best long-term & short-term Moderna share price prognosis for 2024, 2024, …
Web20 jan. 2024 · Moderna Stock Forecast $188.40 was a big level going back to February of last year. The stock eventually broke above in summer 2024 and staged a successful pullback test before marching...
Web6 uur geleden · Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration … spacy active learningWebVandaag · The Weekly Buzzing Stocks by Billy Kawasaki $145.790 Unknown RISKY Moderna(MRNA-Q) 14/12/2024 +Get Signals+Get Signals They just had a breakthrough with a cancer drug they had long been developing. With that, Moderna doesn't need the potential Covid-vaccine business with China (if that happens there). teams uccWeb1 dag geleden · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or … spacy boxWeb1 uur geleden · -- Stephane Bancel, Director, Chief Executive Officer, on April 12, 2024, sold 80,000 shares in Moderna for $12,697,675. Following the Form 4 filing with the SEC, Bancel has control over a total of... April 14, 2024 spacy classificationWeb11 apr. 2024 · According to analysts' consensus price target of $181.27, Moderna has a forecasted upside of 16.8% from its current price of $155.25. Amount of Analyst … spac willie nelsonWebStock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. spacy classifierWeb20 jul. 2024 · Miraculous price movement Moderna looks ready to take on the world, with the efficacy of its new cancer vaccine turning heads. Shares in Moderna skyrocketed by almost 20% yesterday in its biggest single day price jump of the year. The pharmaceutical company has managed to weather 2024 market conditions without too drastic a drop, but … spacy alternative